Frontiers in Medicinal Chemistry 2017 in Bern, Switzerland. (Q47262276)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941184%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

title

Frontiers in Medicinal Chemistry 2017 in Bern, Switzerland (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941184%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941184%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Jean-Louis Reymond

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941184%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1

Daniel Probst

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941184%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

author name string

Marc Heitz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941184%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Marion Poirier

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941184%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Clémence Delalande

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941184%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

publication date

22 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941184%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941184%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941184%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

issue

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941184%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

page(s)

1645-1651

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941184%20AND%20SRC:MED&resulttype=core&format=json

DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation

31 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

A chemical probe toolbox for dissecting the cancer epigenome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Light-controlled modulation of gene expression by chemical optoepigenetic probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Chemical phylogenetics of histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Dynamic Chromatin Regulation from a Single Molecule Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Traceless Synthesis of Asymmetrically Modified Bivalent Nucleosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Structure-guided development of heterodimer-selective GPCR ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Visualization and ligand-induced modulation of dopamine receptor dimerization at the single molecule level

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Chemical Biology Probes from Advanced DNA-encoded Libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Acid- and Au(i)-mediated synthesis of hexathymidine-DNA-heterocycle chimeras, an efficient entry to DNA-encoded libraries inspired by drug structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Replication fork stability confers chemoresistance in BRCA-deficient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Differential Water Thermodynamics Determine PI3K-Beta/Delta Selectivity for Solvent-Exposed Ligand Modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Small-molecule factor D inhibitors targeting the alternative complement pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Preclinical assessment of a novel small molecule inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Endocannabinoid transport revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Targeted protein degradation by PROTACs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Induced protein degradation: an emerging drug discovery paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Targeted inhibition of the COP9 signalosome for treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Structure-Based Design of β5c Selective Inhibitors of Human Constitutive Proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Targeted recombinant fusion proteins of IFNγ and mimetic IFNγ with PDGFβR bicyclic peptide inhibits liver fibrogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

WNT-5A regulates TGF-β-related activities in liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Counting on natural products for drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Deep Learning in Drug Discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

High-Throughput Fragment Docking into the BAZ2B Bromodomain: Efficient in Silico Screening for X-Ray Crystallography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Discovery of CREBBP Bromodomain Inhibitors by High-Throughput Docking and Hit Optimization Guided by Molecular Dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

New Lycopodine-Type Alkaloids from Lycopodium carinatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Asymmetric Total Synthesis of Sarpagine-Related Indole Alkaloids Hydroxygardnerine, Hydroxygardnutine, Gardnerine, (E)-16-epi-Normacusine B, and Koumine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Limiting the Number of Potential Binding Modes by Introducing Symmetry into Ligands: Structure-Based Design of Inhibitors for Trypsin-Like Serine Proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Biarylalkyl Carboxylic Acid Derivatives as Novel Antischistosomal Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

O-Alkylated heavy atom carbohydrate probes for protein X-ray crystallography: Studies towards the synthesis of methyl 2-O-methyl-L-selenofucopyranoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

Chemoproteomics-Enabled Discovery of a Potent and Selective Inhibitor of the DNA Repair Protein MGMT

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201700306

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CMDC.201700306

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941184%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference